Pancreatic Cancer Research

ResearcherCornell UniversityActive in the last 2 years

Michele Cioffi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4180-5369; OpenAlex author ID A5075654305. Sources: OpenAlex.

Their work

Papers
11 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
24
Papers, trials and grants by year

2012: 2 papers · 2013: 1 paper · 2014: 1 paper · 2015: 4 papers · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: none · 2023: 1 paper · 2024: 1 paper

Papers 11

  1. Multi-parametric atlas of the pre-metastatic liver for prediction of metastatic outcome in early-stage pancreatic cancer. Co-author DOI 10.1038/s41591-024-03075-7↗
  2. Complete Remission of Widely Metastatic Human Epidermal Growth Factor Receptor 2-Amplified Pancreatic Adenocarcinoma After Precision Immune and Targeted Therap… Co-author DOI 10.1200/po.21.00489↗
  3. Complete remission in a patient with widely metastatic HER2-amplified pancreatic adenocarcinoma following multimodal therapy informed by tumor sequencing and o… Co-author DOI 10.1101/2021.12.16.21267326↗
  4. The miR-17-92 cluster counteracts quiescence and chemoresistance in a distinct subpopulation of pancreatic cancer stem cells. Co-author DOI 10.1136/gutjnl-2014-308470↗
  5. Microenvironmental hCAP-18/LL-37 promotes pancreatic ductal adenocarcinoma by activating its cancer stem cell compartment. Co-author DOI 10.1136/gutjnl-2014-308935↗
  6. Inhibition of CD47 Effectively Targets Pancreatic Cancer Stem Cells via Dual Mechanisms. Co-author DOI 10.1158/1078-0432.ccr-14-1399↗
  7. Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies. First author DOI 10.3791/52801↗
  8. Chloroquine targets pancreatic cancer stem cells via inhibition of CXCR4 and hedgehog signaling. Co-author DOI 10.1158/1535-7163.mct-13-0948↗
  9. Metformin targets the metabolic achilles heel of human pancreatic cancer stem cells. First author DOI 10.1371/journal.pone.0076518↗
  10. EpCAM/CD3-Bispecific T-cell engaging antibody MT110 eliminates primary human pancreatic cancer stem cells. Co-author DOI 10.1158/1078-0432.ccr-11-1270↗
  11. Immuno-targeting of pancreatic cancer stem cells: A new therapeutic strategy against a devastating disease? Co-author DOI 10.4161/onci.19368↗

Closest collaborators

The 24 strongest of 24 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Christopher Heeschen · 8 shared papers, 2012–2015 · strength 0.38
  2. Manuel M. Hidalgo · 5 shared papers, 2013–2015 · strength 0.21
  3. George A. Poultsides · 2 shared papers, 2021–2023 · strength 0.21
  4. William Arthur Hoos · 2 shared papers, 2021–2023 · strength 0.21
  5. Calvin Jay Kuo · 2 shared papers, 2021–2023 · strength 0.21
  6. Joseph M. Herman · 2 shared papers, 2021–2023 · strength 0.21
  7. Daniel Tandel Chang · 2 shared papers, 2021–2023 · strength 0.21
  8. Daniel A. King · 2 shared papers, 2021–2023 · strength 0.21
  9. George Albert Fisher · 2 shared papers, 2021–2023 · strength 0.21
  10. William E. Gillanders · 2 shared papers, 2021–2023 · strength 0.21
  11. Bruno Sáinz · 4 shared papers, 2014–2015 · strength 0.17
  12. Sara Maria David Trabulo · 4 shared papers, 2013–2015 · strength 0.17
  13. Enza Lonardo · 3 shared papers, 2013–2015 · strength 0.15
  14. Patricia Sancho Andrés · 3 shared papers, 2013–2015 · strength 0.14
  15. Mert Erkan · 3 shared papers, 2014–2015 · strength 0.13
  16. Jorg H. Kleeff · 3 shared papers, 2014–2015 · strength 0.13
  17. Jorge Dorado · 3 shared papers, 2012–2015 · strength 0.12
  18. Anamaria Balic · 2 shared papers, 2013–2014 · strength 0.08
  19. William Greenhalf · 1 shared paper, 2015 · strength 0.05
  20. Eithne Costello · 1 shared paper, 2015 · strength 0.05
  21. Stephan A. Hahn · 1 shared paper, 2015 · strength 0.04
  22. Sonia Alcalá · 1 shared paper, 2015 · strength 0.04
  23. Patrick Christian Hermann · 1 shared paper, 2015 · strength 0.04
  24. Susana Garcı́a-Silva · 1 shared paper, 2015 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.